Greenfern is listed on the New Zealand Stock Exchange under the ticker GFI.

How to invest | You can purchase shares in Greenfern through a NZX participant like Sharesies, your investment advisor or with any other NZX participant as listed here.

NZX Profile
Our Board
Latest News

Cannabis Therapeutics

Greenfern Industries is a therapeutics company based in Taranaki, New Zealand - sitting alongside, and powered by, a small hydro power station with views to the stunning Mount Taranaki.

We produce therapeutic and wellness products that improve the lives of people suffering, those people that also seek an alternative and more holistic approach to health.

We operate on a non-negotiable pillar of environmental sustainability and are a certified carbon zero organisation under the ISO 14064 standard.

Our state-of-the-art facility is being built in the middle of dairy, oil and gas country - allowing us to showcase a clean and environmentally-friendly, alternative-industry option for both the Taranaki region and New Zealand.

Patients before profit

Environmental Sustainability


Medicinal Cannabis

We cultivate premium and consistent quality cannabis and through research and development we are creating a pharmaceutical grade product range.

Hydro Power

Located on-site at a hydro power station that we own. Our Taranaki operation is powered by clean green low-cost renewable hydro power with all excess power sold back to the grid.


Our motivation is drawn from Theo’s story, a story of the difference that Cannabis extracts can make to the lives of those suffering from epilepsy and their families.


Greenfern reaches agreement with Cannvalate to develop its cannabis medicine sales in Australia

Greenfern reaches agreement with Cannvalate to develop its cannabis medicine sales in Australia

Greenfern Industries has reached an agreement with Australian-based Cannvalate Pty which will assist Greenfern (GFI) to develop its cannabis medicine sales in Australia, which are marketed under the GFI Pharma brand.

GFI chairman Brent King said the transaction includes the issuance of shares in Taranaki-based Greenfern to a value of NZD $900,000. GFI and Cannvalate will now move to finalise an agreement, which is compliant with Australian and New Zealand law and NZX listing rules.

Cannvalate has agreed to continue to range of GFI Pharma-branded medications and, under the terms of the agreement, they will educate physicians with the intention of securing exposure to 6000 patients. The agreement also means that GFI will have access to anonymised patient data which will contribute to the company’s research and development initiatives so it can develop and refine specific medications based on real world patient experiences.

Read more
Greenfern enters HOA with Vortex Group

Greenfern enters HOA with Vortex Group

Greenfern Industries has entered into an exclusive Heads of Agreement with Rotorua-based Vortex Group to negotiate a development agreement that could see the two companies jointly develop a renewable energy hydropower generation plant at Normanby, Taranaki for their mutual benefit.
Read more
Trichomes explained

Trichomes explained

Today we’re talking about trichomes - those tiny little crystal-looking structures that cover the leaves and buds of cannabis. 

The word trichomes comes from the Greek word trichōma, meaning hair. Trichomes are fine outgrowths on plants, algae and lichens. On cannabis they tend to be shiny, sticky, carry intense aromas and kind of look like a blanket of frost at first glance.

Read more


Small community roots. Big important vision.

We’re on a mission to show people that cannabis is something that can improve the well-being of individuals and communities.

Keep in touch


Supported by